ICD-11 5A00: Hypothyroidism Diagnosis & Coding Guide

Key Takeaways

ICD-11 5A00 is the primary diagnostic code for hypothyroidism under WHO’s new classification system

Documentation requires TSH levels, thyroid function test results, and clinical presentation details

5A00 subcodes cover congenital (5A00.0), iodine-deficiency (5A00.1), and acquired (5A00.2) hypothyroidism; secondary hypothyroidism uses 5A61.40

ICD-11 implementation timelines vary by country-check local health authority guidance

Proper coding supports accurate billing, population health tracking, and treatment planning

ICD-11 5A00: Hypothyroidism Diagnosis & Coding Guide

The World Health Organization’s ICD-11 classification system introduces significant structural changes for endocrine disorder coding. ICD-11 5A00 serves as the foundation code for hypothyroidism, replacing the fragmented ICD-10 approach with a more granular and clinically aligned framework. For endocrinology practices, understanding this transition matters for three reasons: accurate reimbursement, standardised global health data reporting, and integration with modern EHR systems designed around ICD-11 architecture.

Hypothyroidism affects approximately 5% of the general population, with higher prevalence in women over 60. Accurate coding matters because it determines insurance coverage for lifelong thyroid hormone replacement therapy, tracks disease burden across populations, and enables research into treatment outcomes. Unlike ICD-10’s scattered thyroid codes, ICD-11 5A00 consolidates the condition into a single parent entity with logical child codes for aetiology and severity.

This guide covers clinical criteria for ICD-11 5A00 hypothyroidism diagnosis, documentation requirements for compliant coding, subcategory selection rules, and practical transition strategies from ICD-10 to ICD-11 for endocrinology and primary care practices.

What is ICD-11 Code 5A00 for Hypothyroidism?

ICD-11 code 5A00 represents hypothyroidism within the Endocrine, nutritional or metabolic diseases chapter. According to the WHO ICD-11 Browser, 5A00 is classified under “Diseases of the thyroid gland or thyroid hormones system” and encompasses all forms of insufficient thyroid hormone production. The code structure uses pre-coordinated subcodes (5A00.0, 5A00.1, 5A00.2, 5A00.Z) to specify aetiology, with further granularity under acquired hypothyroidism (5A00.20–5A00.2Z).

The WHO defines hypothyroidism through 5A00 as a clinical syndrome resulting from thyroid hormone deficiency. This definition differs from ICD-10’s E03 series by incorporating functional classification directly into the coding hierarchy. ICD-11 uses specific subcodes to distinguish presentations (e.g., 5A00.22 for subclinical iodine-deficiency hypothyroidism, 5A00.21 for myxoedema coma). This pre-coordinated approach reduces coding errors and improves data quality for epidemiological research.

ICD-11 5A00 includes the following subcategories: 5A00.0 (Congenital hypothyroidism) for cases detected through newborn screening, 5A00.1 (Iodine-deficiency-related thyroid disorders or allied conditions), 5A00.2 (Acquired hypothyroidism) covering the majority of adult-onset cases including autoimmune thyroiditis, and 5A00.Z (Hypothyroidism, unspecified). Under acquired hypothyroidism, further granularity is available: 5A00.20 (due to medicaments or exogenous substances), 5A00.21 (Myxoedema coma), 5A00.22 (Subclinical iodine-deficiency hypothyroidism), 5A00.2Y (Other specified acquired hypothyroidism), and 5A00.2Z (Acquired hypothyroidism, unspecified). Note that postprocedural hypothyroidism (e.g., post-thyroidectomy) is coded separately as 5D40, not under 5A00. Secondary (central) hypothyroidism due to pituitary or hypothalamic dysfunction is coded as 5A61.40, not as a subcode of 5A00.

Clinical Criteria for ICD-11 5A00 Hypothyroidism Diagnosis

Diagnosing hypothyroidism for ICD-11 5A00 coding requires both laboratory evidence and clinical presentation. The American Thyroid Association defines biochemical hypothyroidism as elevated TSH with low or low-normal free T4. TSH reference ranges typically fall between 0.4-4.0 mIU/L, though some laboratories use narrower ranges. Clinicians must document the specific TSH value, reference range, and whether the result represents screening or confirmatory testing.

Clinical signs supporting ICD-11 5A00 diagnosis include fatigue, cold intolerance, weight gain despite stable caloric intake, constipation, dry skin, and delayed reflexes. Subclinical hypothyroidism presents with elevated TSH but normal free T4, often accompanied by subtle symptoms. Overt hypothyroidism shows elevated TSH and low free T4, with more pronounced clinical features. Documentation must distinguish between these presentations because treatment decisions and coding specificity depend on disease severity.

Differential diagnosis requires ruling out conditions that mimic hypothyroidism. Non-thyroidal illness can suppress TSH temporarily. Medication effects-particularly lithium, amiodarone, and interferon-can induce hypothyroidism or alter test results. Pituitary disorders may present with low TSH and low T4, requiring distinction from primary hypothyroidism. The clinical record must document ruled-out diagnoses to support ICD-11 5A00 code selection over alternative endocrine codes.

Laboratory Values and Diagnostic Thresholds

TSH elevation above the upper reference limit forms the primary diagnostic criterion. Most guidelines recommend treatment when TSH exceeds 10 mIU/L regardless of symptoms. For TSH values between 4.5-10 mIU/L, clinical judgement determines treatment based on symptom severity, anti-thyroid antibody presence, and cardiovascular risk factors. AI-powered clinical documentation tools can flag borderline values for clinician review during the diagnostic workflow.

Free T4 measurement confirms diagnosis severity. Overt hypothyroidism shows free T4 below the laboratory reference range, typically under 0.8 ng/dL. Subclinical hypothyroidism maintains normal free T4 despite elevated TSH. Some practices measure free T3, though this adds limited diagnostic value for most hypothyroidism cases. Documentation should record all thyroid function tests performed, their values, and the specific laboratory reference ranges used.

Anti-thyroid peroxidase (anti-TPO) antibodies identify autoimmune aetiology. Positive anti-TPO antibodies appear in 90% of Hashimoto’s thyroiditis cases, the most common cause of primary hypothyroidism in iodine-sufficient regions. This test result influences ICD-11 5A00 subcategory selection and provides prognostic information about disease progression. Thyroid ultrasound may reveal characteristic autoimmune changes, though imaging findings don’t alter the ICD-11 5A00 parent code assignment.

ICD-11 5A00 Subcategories and Code Selection

ICD-11 5A00 branches into multiple subcategories based on aetiology. Primary hypothyroidism constitutes the most common subcategory, resulting from intrinsic thyroid gland failure. Causes include chronic autoimmune thyroiditis, radioactive iodine treatment, thyroidectomy, external beam radiation, and congenital thyroid dysgenesis. Each cause may warrant additional codes from the ICD-11 causation chapter to capture full clinical context. Functional medicine practices often document root causes extensively, making subcategory selection straightforward.

Secondary (central) hypothyroidism is not coded under 5A00 but uses ICD-11 code 5A61.40 (Acquired central hypothyroidism). This distinction is important: 5A00 covers primary and congenital hypothyroidism only. Secondary hypothyroidism requires documentation of the underlying pituitary or hypothalamic pathology—most commonly pituitary adenomas, pituitary surgery, or cranial radiation. Laboratory findings show low or inappropriately normal TSH with low free T4. The clinical record must demonstrate workup for pituitary disease before assigning 5A61.40.

Congenital hypothyroidism receives dedicated subcategories for cases detected through newborn screening. Most health systems mandate thyroid screening within the first week of life. Early detection prevents irreversible neurodevelopmental delays. Congenital hypothyroidism codes distinguish between thyroid dysgenesis, dyshormonogenesis, and transient forms caused by maternal antithyroid antibodies. Genetic testing results may support subcategory selection when available.

ICD-11 5A00 Subclinical vs Overt Hypothyroidism Coding

ICD-11 handles the subclinical vs overt distinction through pre-coordinated subcodes rather than post-coordination extensions. Subclinical iodine-deficiency hypothyroidism uses subcode 5A00.22. Most acquired hypothyroidism (including overt cases from autoimmune thyroiditis) falls under 5A00.2Z or 5A00.2Y depending on specificity available. Myxoedema coma, the most severe presentation, has its own dedicated subcode 5A00.21. This pre-coordinated approach ensures consistent coding without requiring clinicians to construct complex post-coordinated expressions.

Subcode selection affects reimbursement for some insurers that tie payment to disease acuity. It also influences claims management workflows because severe hypothyroidism justifies more frequent monitoring and specialist consultations. Documentation must include objective severity markers: TSH level, free T4 level, clinical signs of severe disease, and treatment response. Without these elements, coding auditors may question subcode selection.

Documentation Requirements for ICD-11 5A00 Hypothyroidism Coding

Compliant ICD-11 5A00 coding requires specific documentation elements in the clinical record. First, record the TSH value, free T4 value, and laboratory reference ranges. Second, document clinical signs supporting the diagnosis-list at least three symptoms with their onset dates and severity. Third, note any prior thyroid function tests to establish disease chronicity or acute presentation. Fourth, record the suspected or confirmed aetiology with supporting evidence.

Treatment decisions must appear in the record to justify diagnosis coding. For subclinical hypothyroidism with TSH 4.5-10 mIU/L, document why treatment was initiated or deferred. Include factors such as pregnancy status, cardiovascular risk, symptom burden, and anti-TPO antibody results. For overt hypothyroidism, record the initial levothyroxine dose and target TSH range. This treatment documentation supports medical necessity for ongoing monitoring and medication refills.

Differential diagnosis documentation strengthens ICD-11 5A00 code assignment. Note any conditions considered and ruled out: non-thyroidal illness, medication-induced thyroid dysfunction, pituitary disease, or pregnancy-related thyroid changes. If anti-TPO antibodies were negative, document consideration of other causes such as iodine deficiency, drug effects, or infiltrative disease. Comprehensive differential documentation reduces audit risk and supports appropriate code selection.

ICD-11 5A00 Coding Workflows for Endocrinology Practices

Establish standardised workflows for ICD-11 5A00 assignment during clinical encounters. When ordering thyroid function tests, flag the chart for diagnosis coding review once results return. Build EHR templates that prompt clinicians to document required elements: TSH value, reference range, free T4, clinical symptoms, and suspected cause. Pre-populate subcode suggestions based on clinical context while allowing clinician override for complex cases.

Train clinical staff to recognise when hypothyroidism coding requires additional specificity. New diagnoses need thorough workup documentation. Follow-up visits require TSH trend documentation and treatment adjustment rationale. Digital intake forms can capture symptom updates between visits, providing continuous documentation for disease severity tracking. This longitudinal data supports accurate ICD-11 5A00 coding at each encounter.

Transitioning from ICD-10 to ICD-11 5A00 Hypothyroidism Codes

ICD-10 distributes hypothyroidism across E00–E03 and E89.0 codes. ICD-11 reorganises these under 5A00 with pre-coordinated subcodes. Key mappings: E03.9 (hypothyroidism, unspecified) → 5A00.2Z; E00.x (congenital iodine-deficiency syndromes) → 5A00.0 or 5A00.1; E02 (subclinical iodine-deficiency hypothyroidism) → 5A00.22; E03.0–E03.5 (other acquired forms) → 5A00.2Y or 5A00.2Z; E89.0 (postprocedural hypothyroidism) → 5D40 (not under 5A00). Review each ICD-10 thyroid code used in your practice and map to the correct ICD-11 subcode.

The WHO publishes official ICD-10 to ICD-11 mapping tables that specify one-to-many and many-to-one relationships. For example, ICD-10 E03.9 (hypothyroidism, unspecified) maps to 5A00.2Z (acquired hypothyroidism, unspecified). ICD-10 E03.0 (congenital hypothyroidism with diffuse goitre) maps to 5A00.0 (congenital hypothyroidism). ICD-10 E89.0 (postprocedural hypothyroidism) maps to 5D40, which sits outside the 5A00 hierarchy entirely. Download these WHO mapping tables and validate them against your practice’s diagnosis patterns.

Implementation timelines vary by country and payer. The United States has not yet mandated ICD-11 for reimbursement-most practices continue using ICD-10-CM. The United Kingdom and European Union nations adopted ICD-11 for mortality reporting in 2022, with morbidity coding following on staggered schedules. Check with your national health authority and major insurers for transition deadlines. Build dual-coding capabilities into your EHR to maintain ICD-10 for billing while preparing ICD-11 infrastructure.

Prepare Your Practice for ICD-11 Transition

Pabau supports both ICD-10 and ICD-11 coding with automated mapping, structured documentation templates, and claims validation. Book a demo to see how our platform simplifies endocrine disorder coding.

Book a demo

ICD-11 5A00 Training for Clinical and Coding Staff

Train clinicians on ICD-11 5A00 structural differences before implementation. Focus on three areas: parent code selection rules, subcode logic based on aetiology (5A00.0 vs 5A00.1 vs 5A00.2), and when to use 5D40 or 5A61.40 instead of 5A00. Use real patient cases from your practice to demonstrate code assignment decisions. Highlight situations where ICD-11 requires different specificity than ICD-10, such as distinguishing subclinical iodine-deficiency hypothyroidism (5A00.22) from acquired hypothyroidism (5A00.2Z), and recognising that postprocedural cases use 5D40 instead of 5A00.

Coding staff need training on ICD-11’s subcode structure for hypothyroidism. While ICD-11 does support post-coordination for some conditions, 5A00 primarily uses pre-coordinated subcodes (5A00.0, 5A00.1, 5A00.2x, 5A00.Z). Provide practice exercises where coders assign the correct 5A00 subcode based on clinical documentation. Review common errors such as using 5A00.Z when more specific subcodes are supported by documentation, or coding postprocedural hypothyroidism under 5A00 instead of 5D40.

Establish feedback loops between coding and clinical teams. When coders identify missing documentation, create specific feedback reports listing required elements. When clinicians question code assignments, provide educational responses explaining ICD-11 5A00 selection rules. Monthly coding accuracy audits catch systematic errors early. Team collaboration tools facilitate these communication workflows between clinical and administrative staff.

ICD-11 5A00 Hypothyroidism and EHR Integration

Modern EHR systems integrate ICD-11 5A00 coding through structured data entry. When clinicians document TSH and free T4 values in laboratory result fields, the EHR can automatically suggest appropriate ICD-11 codes. Clinical decision support tools compare laboratory values against diagnostic thresholds and flag results warranting attention. This automation reduces coding errors and ensures documentation completeness for audit defence.

Problem list management requires updating historical diagnoses from ICD-10 to ICD-11 format. Some EHR systems perform bulk updates based on mapping tables. Others require manual review for each patient. Prioritise conversion for patients with active hypothyroidism management-those on levothyroxine with regular monitoring. Inactive historical diagnoses can convert on a slower timeline. Tag converted diagnoses to track migration progress and identify any mapping errors.

Reporting and analytics dashboards must adapt to ICD-11 structure. Quality measures tracking hypothyroidism screening rates or treatment adherence need updated code lists. Population health queries searching for thyroid disorders should include all ICD-11 5A00 subcategories. Test reporting logic before go-live to prevent gaps in chronic disease management programs. Advanced reporting features allow practices to track diagnosis trends across both coding systems during the transition period.

Billing and Reimbursement with ICD-11 5A00 Hypothyroidism Codes

Reimbursement for hypothyroidism management depends on accurate ICD-11 5A00 code assignment. Most payers cover levothyroxine prescriptions and TSH monitoring for documented hypothyroidism. However, subclinical hypothyroidism with TSH 4.5-7.0 mIU/L may face coverage restrictions. Documentation must justify treatment decisions in borderline cases by citing symptoms, antibody presence, or comorbid conditions. Pre-authorisation requirements vary by payer-check local policies.

Specialist consultations require ICD-11 5A00 coding to demonstrate medical necessity. Initial endocrinology evaluation for new-onset hypothyroidism typically receives coverage. Follow-up frequency depends on disease stability: quarterly visits for uncontrolled cases, annual visits once stable. Documentation should state visit purpose, findings prompting specialist involvement, and treatment adjustments made. These elements support continued specialist care authorisation.

Claim denials related to ICD-11 5A00 coding often result from insufficient documentation of severity or aetiology. When a payer downgrades a claim, review the clinical record for missing elements. Add documentation through addenda if permissible under your jurisdiction’s rules. For future claims, enhance templates to capture required specificity at the point of care. Track denial patterns by payer and ICD-11 5A00 subcategory to identify systemic documentation gaps.

ICD-11 5A00 for Multi-Location Endocrinology Practices

Multi-location practices face unique challenges implementing ICD-11 5A00 coding consistently. Each site may use different EHR workflows or documentation styles. Establish enterprise-wide coding standards before transition. Create a master ICD-11 5A00 coding manual documenting when to use each subcode (5A00.0, 5A00.1, 5A00.2x, 5A00.Z, or 5D40 for postprocedural cases). Distribute this manual to all locations and require clinician acknowledgment of receipt.

Centralised coding audits identify site-specific variation. Pull monthly reports showing ICD-11 5A00 code distribution by location. Flag sites with unexpectedly high 5A00.Z (unspecified) usage when more specific subcodes are clinically supported. Conduct targeted training at outlier locations. Share best practices from high-performing sites across the network. Multi-location management features facilitate enterprise-level quality monitoring and standardisation efforts.

Patient transfers between locations require diagnosis reconciliation. When a patient moves from one site to another, verify ICD-11 5A00 coding consistency. Update problem lists if the transferring site used different subcategories (e.g., 5A00.2Z vs 5A00.2Y). Document any changes in clinical status that justify code modifications. This reconciliation prevents confusion about disease severity and treatment goals.

Expert Picks

Need structured thyroid function documentation? Psychiatric Evaluation Template demonstrates comprehensive symptom documentation approaches adaptable to endocrine assessments.

Tracking multiple chronic conditions? Client Record Management centralises diagnosis histories, lab trends, and treatment adjustments across all patient encounters.

Implementing new coding standards across teams? Team Management Software distributes training materials and tracks staff competency with structured workflows.

Conclusion

ICD-11 5A00 provides a more clinically coherent framework for hypothyroidism coding compared to ICD-10’s scattered approach. The system’s post-coordination capabilities allow precise severity and aetiology specification while maintaining a single parent code for epidemiological tracking. Successful transition requires updated documentation templates, staff training on new coding rules, and EHR configuration supporting both structure and clinical workflow.

Practices should begin preparing now even if local mandates remain years away. Build ICD-11 5A00 mapping tables from existing ICD-10 diagnoses. Test documentation workflows to ensure they capture required elements. Train clinical staff on diagnostic criteria differences that affect code selection. These preparatory steps reduce disruption when regulatory deadlines arrive and position practices to leverage ICD-11’s analytical advantages immediately upon implementation.

Frequently Asked Questions